Validation Summary Report (VSR)
Equipment: Slitting Machine
Subcategory: Transdermal Patches (TDS)
Area: Production
Summary
This Validation Summary Report outlines the validation activities conducted for the Slitting Machine used in the production of Transdermal Patches. The validation process includes Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ), all of which have been executed successfully.
Scope/Boundaries
The scope of this validation includes the assessment of the Slitting Machine’s capabilities, focusing on the critical parameters identified in the User Requirement Specification (URS) Annex 11. This report covers the validation activities performed within the production area, specifically for the manufacturing of transdermal patches.
Executed Protocol List
- DQ Protocol
- IQ Protocol
- OQ Protocol
- PQ Protocol
Deviations Summary
No significant deviations were noted during the validation process. All protocols were executed as planned, adhering to the acceptance criteria outlined in the URS Annex 11.
CPP Verification Summary
The following key critical parameters were verified:
- Slitting width
- Blade alignment
- PLC logs
All critical parameters met the acceptance criteria as specified in the URS Annex 11.
Conclusion
The Slitting Machine has successfully passed all validation phases (DQ, IQ, OQ, PQ) with no deviations. The equipment is deemed qualified for use in the production of Transdermal Patches, with a requalification frequency of 12 months.
Attachments Index
- Attachment 1: DQ Protocol Document
- Attachment 2: IQ Protocol Document
- Attachment 3: OQ Protocol Document
- Attachment 4: PQ Protocol Document
Approvals
_____________________
Validator Name
Date
_____________________
Quality Assurance Name
Date